摘要
背景:维甲酸外用的临床疗效已被广泛研究,并已被广泛应用于许多治疗措施,其中包括光老化、痤疮和黄褐斑。然而,IDE效应,主要是皮肤刺激,红斑,干燥和脱皮,仍然是患者依从性的主要障碍。此外,对药物释放状况的洞察力对于忍受药物的治疗作用。 方法:通过数据库中的文献研究,重点介绍维A酸载体系统的进一步进展和最新进展,如脂质体、固体脂质纳米颗粒、纳米李分子等。PID载体,环糊精,纳米结构聚合物和其他技术系统,以减少其副作用和改善渗透剖面,以提高药效和药物安全性。 结果:研制了猪耳、蛇、小鼠和人皮肤体外通透性模型,并对药物制剂进行了评价,并对其刺激性进行了验证。维甲酸的租赁制度及与现有商业制剂的比较。总体结果表明,系统的组成、电荷和大小对维甲酸的释放有影响,对t有调节作用。他的释放类型和它的保留。小的单层囊泡促进了维甲酸的更大的皮肤输送。负电荷对脂质体和硝基苯体都有促进猪皮水化的作用。Ell作为维甲酸的保留物。固体脂质含量和固体脂质纳米粒和纳米脂质载体组成中所使用的油脂种类对经皮药物剥离有影响。[医] 丹毒丝菌属 结论:从文献中可以清楚地看出,维甲酸技术给药系统是一种创新和潜在的管理方法,以提高患者的依从性、安全性和有效性。calcyclin 钙细胞周期蛋白.
关键词: 维甲酸,局部给药,纳米技术,副作用,维甲酸释放,体外渗透。
Current Medicinal Chemistry
Title:Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy
Volume: 25 Issue: 31
关键词: 维甲酸,局部给药,纳米技术,副作用,维甲酸释放,体外渗透。
摘要: Background: The clinical efficacy of the topical tretinoin is widely studied and has been well established for many therapeutic interventions, among some, photoaging, acne, and melasma. However, the side effects, mainly cutaneous irritation, erythema, xerosis and peeling, remain major obstacle to the patient compliance. Besides, the insight regarding the drug delivery profile is essential to understand the therapeutic action of the drug.
Methods: Through bibliographic research in databases we highlight further advances and an update on tretinoin delivery systems such as liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, cyclodextrins, nanostructured polymers and other technological systems that reduce its side effects and improve the permeation profile to potentiate efficacy and drug safety on the skin.
Results: Pharmaceutical preparations were developed and evaluated for permeability in in vitro models using pig ear, snake, mouse and human skin, and potential for irritation was also verified using release systems for tretinoin and compared to available commercial formulations. Overall results indicated the composition, charge and size of the system influences the tretinoin delivery, modulating the type of release and its retention. Small unilamellar vesicles promoted greater cutaneous delivery of tretinoin. Negative charge, for both liposomes and niosomes, can improve pig skin hydration as well as the tretinoin retention. The quantity of solid lipids and the type of oil used in the composition of solid lipid nanoparticles and nanostructured lipid carriers affected percutaneous drug delivery.
Conclusion: As evident from the literature, the tretinoin technological delivery systems consist an innovative and potential management for increasing the patient compliance presenting safety and efficacy.
Export Options
About this article
Cite this article as:
Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy, Current Medicinal Chemistry 2018; 25 (31) . https://dx.doi.org/10.2174/0929867325666180313110917
DOI https://dx.doi.org/10.2174/0929867325666180313110917 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
High Throughput Screening of Physicochemical Properties and In Vitro ADME Profiling in Drug Discovery
Combinatorial Chemistry & High Throughput Screening Synthesis and Characterization of Two New Thiophene Acetyl Salicylic Acid Esters and their ortho- and para-effect on Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Current Alzheimer Research Lipid-Drug Conjugates for Oral Bioavailability Enhancement
Recent Patents on Nanomedicine A Water-Soluble Fenbendazole (FBZ) Formulation for Treating Pinworm Infections in Laboratory Animals
Drug Delivery Letters Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics
Current Cancer Drug Targets An Overview on Chemistry and Biological Importance of Pyrrolidinone
Current Organic Synthesis New Insights into Pre-, Intra- and Post-Operative Brain Mapping in Low- Grade Glioma Surgery: Towards a Longitudinal Study of Cerebral Plasticity
Current Medical Imaging Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms
Current Drug Targets Establishing Genomic/Transcriptomic Links Between Alzheimer’s Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
CNS & Neurological Disorders - Drug Targets Chemical Constituents of Luculia pinceana in Vietnam and Evaluation of their Biological Activity
The Natural Products Journal Potential Anticancer Agents. I. Synthesis of Isoxazole Moiety Containing Quinazoline Derivatives and Preliminarily in vitro Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Biological Evaluation of a New Series of Benzothiazole-Benzothiadiazine Conjugates as Antibacterial Agents
Letters in Drug Design & Discovery Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Daphnane-Type Diterpene Orthoesters and their Biological Activities
Mini-Reviews in Medicinal Chemistry Bioinformatic Analysis Reveals Key Genes and Pathways in Aging Brain of Senescence-accelerated Mouse P8 (SAMP8)
CNS & Neurological Disorders - Drug Targets Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design FtsZ: A Novel Target for Tuberculosis Drug Discovery
Current Topics in Medicinal Chemistry The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of HIV-1 Entry
Current Pharmaceutical Design